<qa>  What is the receptor activator of RANK-ligand directed therapy for prevention of- Concurrent bisphosphonate or receptor activator of nuclear factor kappa-B RANK-ligand directed therapy for prevention of skeletal related events or treatment of osteoporosis is allowed 